ABCELLERA BIOLOGICS Capital Reinvestment Ratio
ABCELLERA BIOLOGICS capital reinvestment ratio. ABCELLERA BIOLOGICS (8QQ) has a Capital Reinvestment Ratio of 0.08x as of June 2026, meaning it reinvests 0% of its operating cash flow (€25.92 Million) in capital expenditures (€2.13 Million). Check ABCELLERA BIOLOGICS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of ABCELLERA BIOLOGICS (2021–2022)
Capital reinvestment ratio of ABCELLERA BIOLOGICS from 2021 to 2022. This chart tracks ABCELLERA BIOLOGICS's Capital Reinvestment Ratio across 2 annual periods. Also explore ABCELLERA BIOLOGICS (8QQ) net asset momentum to track the company's year-over-year net asset growth rate.
ABCELLERA BIOLOGICS Capital Reinvestment Ratio by Year (2021–2022)
ABCELLERA BIOLOGICS capital reinvestment ratio by year from 2021 to 2022. For the full cash flow conversion analysis, see 8QQ operating cash flow.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.26x | €277.36 Million | €72.66 Million | ▲ +9.6% |
| 2021 | 0.24x | €244.58 Million | €58.45 Million | — |